Human Papillomavirus-related Intraepithelial Neoplasia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-17
Clinical Trial Update: To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years [Phase 2]
Phase 2 clinical trial to evaluate the safety and immunogenicity of a 15-valent HPV recombinant vaccine in Chinese people aged 9-45; current…